BioSpace News Archive

The only FDA-approved, ready-to-use oral solution for the acute treatment of migraine with or without aura in adults First step to building a growth platform in Neurology Patent protection until 2036

Inozyme Pharma, Inc. today announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, Aug. 11.

Conference Call to be Held on Wednesday, August 11, 2021 at 5:00 p.m. (EDT)

Surmodics, Inc. , today announced results for its fiscal 2021 third quarter ended June 30, 2021 and updated its financial outlook for its fiscal 2021.

Agreement provides Schrödinger and Zai Lab with pipeline expansion opportunities in precision oncology

Immunovia AB today announced that Immunovia, Inc. has received final approval to begin patient testing for the IMMray PanCan-d test

EDAP TMS SA, the global leader in robotic energy-based therapies, reports select preliminary unaudited second quarter financial and operating results.

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11, 2021 at 2:00 p.m. ET.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced that members of management will participate in a fireside chat at the 2021 Wedbush PacGrow Virtual Healthcare Conference on Wednesday, August 11, 2021 at 11:30 a.m. ET.

Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer’s disease, announced that its AlzoSure® prognostic biomarker technology has been awarded a patent in China.